ArticleOncogene2004

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.

Mariana Salatino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.